Ronald Hunt

Insider Reports History

Entity
Individual
Location
C/O Credit Suisse 1 St Boston Prv Eqy, 11 Madison Avenue, New York, NY
Signature
/s/ Ronald M. Hunt
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ronald Hunt:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Iterum Therapeutics plc Director Ordinary Shares 254K $355K $1.40 Aug 6, 2024 By New Leaf Ventures III, L.P.
Iterum Therapeutics plc Director Ordinary Shares 91.1K $128K $1.40 Aug 6, 2024 By New Leaf Biopharma Opportunities II, L.P.
Rallybio Corp Director Option (Right to Buy) 16.5K $29.2K $1.77 May 15, 2024 Direct
Iterum Therapeutics plc Director Warrants (right to buy) 182K Aug 6, 2024 By New Leaf Ventures III, L.P.
Iterum Therapeutics plc Director Warrants (right to buy) 65.5K Aug 6, 2024 By New Leaf Biopharma Opportunities II, L.P.
Harpoon Therapeutics, Inc. Director, 10%+ Owner 8.000% Series A Redeemable Preferred Stock 0 Mar 11, 2024 Indirect
Harpoon Therapeutics, Inc. Director, 10%+ Owner Common Stock 0 Mar 11, 2024 Direct
Harpoon Therapeutics, Inc. Director, 10%+ Owner Common Stock 0 Mar 11, 2024 Indirect
Harpoon Therapeutics, Inc. Director, 10%+ Owner Common Stock Warrant (Right to Buy) 0 Mar 11, 2024 Indirect
Harpoon Therapeutics, Inc. Director, 10%+ Owner Director Stock Option (Right to Buy) 0 Mar 11, 2024 Direct
Iterum Therapeutics plc Director Restricted Share Units 0 Oct 1, 2023 Direct
Iterum Therapeutics plc Director Subscription Rights (right to buy) 0 Aug 6, 2024 By New Leaf Biopharma Opportunities II, L.P.
Iterum Therapeutics plc Director Subscription Rights (right to buy) 0 Aug 6, 2024 By New Leaf Ventures III, L.P.

Insider Reports Filed by Ronald Hunt

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ITRM Iterum Therapeutics plc Aug 6, 2024 8 $0 4 Aug 12, 2024 Director
RLYB Rallybio Corp May 15, 2024 1 $0 4 May 17, 2024 Director
HARP Harpoon Therapeutics, Inc. Mar 8, 2024 12 $0 4 Mar 11, 2024 Director, 10%+ Owner
RLYB Rallybio Corp Jan 2, 2024 1 $51.5K 4 Jan 4, 2024 Director
HARP Harpoon Therapeutics, Inc. Jan 1, 2024 1 $0 4 Jan 3, 2024 Director, 10%+ Owner
HARP Harpoon Therapeutics, Inc. Nov 27, 2023 1 $0 4 Nov 28, 2023 Director, 10%+ Owner
HARP Harpoon Therapeutics, Inc. Oct 25, 2023 4 $0 4 Oct 27, 2023 Director, 10%+ Owner
HARP Harpoon Therapeutics, Inc. Oct 1, 2023 1 $0 4 Oct 2, 2023 Director, 10%+ Owner
ITRM Iterum Therapeutics plc Oct 1, 2023 2 $0 4 Oct 2, 2023 Director
HARP Harpoon Therapeutics, Inc. Jul 1, 2023 1 $0 4 Jul 6, 2023 Director, 10%+ Owner
ITRM Iterum Therapeutics plc Jul 1, 2023 2 $0 4 Jul 3, 2023 Director
HARP Harpoon Therapeutics, Inc. Jun 22, 2023 1 $0 4 Jun 23, 2023 Director, 10%+ Owner
RLYB Rallybio Corp May 17, 2023 1 $0 4 May 19, 2023 Director
HARP Harpoon Therapeutics, Inc. Apr 1, 2023 1 $0 4 Apr 4, 2023 Director, 10%+ Owner
ITRM Iterum Therapeutics plc Apr 1, 2023 2 $0 4 Apr 3, 2023 Director
HARP Harpoon Therapeutics, Inc. Mar 23, 2023 2 $10M 4 Mar 27, 2023 Director, 10%+ Owner
RLYB Rallybio Corp Jan 3, 2023 1 $0 4 Jan 5, 2023 Director
ITRM Iterum Therapeutics plc Jan 1, 2023 2 $0 4 Jan 4, 2023 Director
ITRM Iterum Therapeutics plc Dec 23, 2022 1 $0 4 Dec 28, 2022 Director
ITRM Iterum Therapeutics plc Sep 25, 2022 1 $0 4 Sep 27, 2022 Director
ITRM Iterum Therapeutics plc Jun 25, 2022 1 $0 4 Jun 28, 2022 Director
ITRM Iterum Therapeutics plc Jun 23, 2022 2 $0 4 Jun 24, 2022 Director
HARP Harpoon Therapeutics, Inc. Jun 22, 2022 2 $45K 4 Jun 24, 2022 Director, 10%+ Owner
ITRM Iterum Therapeutics plc Jun 15, 2022 1 $6.47K 4 Jun 17, 2022 Director
RLYB Rallybio Corp May 24, 2022 1 $0 4 May 26, 2022 Director
ITRM Iterum Therapeutics plc Mar 25, 2022 1 $0 4 Mar 29, 2022 Director
RLYB Rallybio Corp Jan 3, 2022 1 $0 4 Jan 5, 2022 Director
RLYB Rallybio Corp Jul 29, 2021 0 $0 3 Jul 29, 2021 Director
RLYB Rallybio Corp Jul 28, 2021 7 $4M 4 Aug 4, 2021 Director
ITRM Iterum Therapeutics plc Jun 23, 2021 1 $0 4 Jun 25, 2021 Director
HARP Harpoon Therapeutics, Inc. May 4, 2021 2 $0 4/A May 14, 2021 Director, 10%+ Owner
HARP Harpoon Therapeutics, Inc. Jan 11, 2021 1 $4M 4 Aug 12, 2021 Director, 10%+ Owner